Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Bicara Therapeutics granted non-qualified stock options to purchase 191,425 shares of common stock to four new employees as a material inducement to employment. The options have an exercise price of $28.91 per share, equal to the closing price on July 1, 2026, and were approved under Nasdaq Listing Rule 5635(c)(4).
Key figures
- Exercise price
- 28.91
- Shares granted
- 191425
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.